Search

everythinglearnresearchcommunity

for

Search:↓

A young woman with visual issues and other symptoms was diagnosed with lupus and antiphospholipid syndrome, and improved with treatment.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Congenital atrichia with papular lesions is often misdiagnosed, and new diagnostic criteria can improve accuracy.

Men with androgenetic alopecia may have higher blood pressure, suggesting early screening for hypertension.

Autoimmune Polyendocrine Syndromes involve specific combinations of endocrine and non-endocrine autoimmune diseases.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

An 11-year-old Greek girl was diagnosed with a rare genetic disorder, highlighting the importance of genetic testing and family history.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Alopecia areata is not linked to vitamin B12 deficiency.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

People with alopecia areata often have low vitamin D levels, which may worsen their hair loss.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Candida antigen is an effective and promising treatment for alopecia areata.

The humanized AA mouse model is better for testing new alopecia areata treatments.

A 24-year-old man developed both alopecia areata universalis and type 1 diabetes at the same time, which is rare.

Higher PSA levels can indicate prostate cancer, but there's overlap with non-cancerous conditions.

Alopecia areata patients often have low vitamin D levels, suggesting they might benefit from vitamin D supplements.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Alopecia areata often starts before age 20, is more common in women, and may have a genetic link with other autoimmune diseases.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Adalimumab may cause severe hair loss in some patients.

Non-invasive methods can effectively diagnose and manage alopecia areata.

Alopecia areata patients have higher hormone levels, suggesting hormonal screening could help in treatment.

Low vitamin D levels are common in people with Alopecia Areata.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.